Altering in vivo membrane sterol composition affects the activity of the cyclic lipopeptides tolaasin and sessilin against Pythium

Biochim Biophys Acta Biomembr. 2022 Oct 1;1864(10):184008. doi: 10.1016/j.bbamem.2022.184008. Epub 2022 Jul 19.

Abstract

Cyclic lipopeptides (CLiPs) are secondary metabolites produced by a variety of bacteria. These compounds show a broad range of antimicrobial activities; therefore, they are studied for their potential applications in agriculture and medicine. It is generally assumed that the primary target of the CLiPs is the cellular membrane, where they can permeabilize the lipid bilayer. Model membrane systems are commonly used to investigate the effect of lipid composition on the permeabilizing activity of CLiPs, but these systems do not represent the full complexity of true biological membranes. Here, we introduce a novel method that uses sterol-auxotrophic oomycetes to investigate how the activity of membrane-active compounds is influenced by alterations in membrane sterol composition. More specifically, we investigated how ergosterol, cholesterol, beta-sitosterol and stigmasterol affect the activity of the structurally related Pseudomonas-derived CLiPs tolaasin and sessilin against the oomycete Pythium myriotylum. Both compounds were effective against oomycetes, although tolaasin was considerably more active. Interestingly, tolaasin and sessilin effects were similarly reduced by the presence of sterols, with cholesterol showing the highest reduction of activity.

Keywords: Cyclic lipopeptides; Membranes; Oomycetes; Pseudomonas; Pythium; Sessilin; Sterols; Tolaasin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Cholesterol / metabolism
  • Lipopeptides / chemistry
  • Peptides, Cyclic / chemistry
  • Pythium* / metabolism
  • Sterols* / metabolism
  • Sterols* / pharmacology

Substances

  • Anti-Bacterial Agents
  • Lipopeptides
  • Peptides, Cyclic
  • Sterols
  • Cholesterol